There is increasing evidence that altered microbiome and gut barrier dysfunction contribute to systemic inflammation in patients with CVID, especially in those with lower levels of IgA and IgM antibodies binding to lipopolysaccharide and low isotype-switched memory B cells. The gene discussed is CD79A; the disease is common variable immunodeficiency.